EDEN Eden Research Plc

TIDMEDEN

Eden Research plc

29 June 2021

29 June 2021

Eden Research Plc

("Eden" or "Company")

Virtual Investor Conference - Link for webinar

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces the details for shareholders wishing to join the virtual investor conference at 1pm on 30 June 2021.

Shareholders wishing to join the meeting may use the following link:

https://us02web.zoom.us/j/86029056624

Shareholders are reminded that there will be no opportunity to ask questions during the meeting as all questions have been submitted in advance.

For further information contact:

 
                                                www.edenresearch.com 
   Eden Research plc 
 Sean Smith 
  Alex Abrey                                    01285 359 555 
 
   Cenkos Securities plc (Nominated advisor 
   and broker) 
 Giles Balleny / Camilla Hume/ Mark Connelly 
  (corporate finance) 
  Michael Johnson (sales)                       020 7397 8900 
 
   Hawthorn Advisors (Financial PR) 
 Lorna Cobbett / Victoria Ainsworth             eden@hawthornadvisors.com 
 

Notes to Editors:

Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's Sustaine(R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.

For more information about Eden, please visit: www.edenresearch.com.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRASEMFSUEFSEEM

(END) Dow Jones Newswires

June 29, 2021 06:27 ET (10:27 GMT)

Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024